Editing Data Dictionary: European mortality database (MDB)

<span style="display:none">europeanunion</span>
Go back to [[Database: European mortality database (MDB) (European Union)]]

The following is a list of labels for variables. A complete data dictionary with all database metadata can be found with the downloadable dataset.

{| class="wikitable"
! Measure labels !!  !! 
|-
| Code || Label || 
|-
| HFA_1 || Mid-year population, by sex || 
|-
| HFA_2 || Mid-year male population || 
|-
| HFA_3 || Mid-year female population || 
|-
| HFAMDB_1 || Accidental drowning and submersion, number of deaths, by sex || 
|-
| HFAMDB_2 || Accidental drowning and submersion, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_3 || Accidental drowning and submersion, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_4 || Accidental drowning and submersion, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_5 || Accidental drowning and submersion, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_6 || Accidental drowning and submersion, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_7 || Accidental drowning and submersion, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_8 || Accidental drowning and submersion, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_9 || Accidental drowning and submersion, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_10 || Accidental drowning and submersion, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_11 || Accidental drowning and submersion, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_12 || Accidental drowning and submersion, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_13 || Accidental drowning and submersion, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_14 || Accidental drowning and submersion, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_15 || Accidental drowning and submersion, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_16 || Accidental drowning and submersion, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_17 || Accidental falls, number of deaths, by sex || 
|-
| HFAMDB_18 || Accidental falls, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_19 || Accidental falls, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_20 || Accidental falls, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_21 || Accidental falls, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_22 || Accidental falls, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_23 || Accidental falls, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_24 || Accidental falls, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_25 || Accidental falls, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_26 || Accidental falls, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_27 || Accidental falls, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_28 || Accidental falls, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_29 || Accidental falls, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_30 || Accidental falls, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_31 || Accidental falls, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_32 || Accidental falls, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_33 || Accidental poisoning, number of deaths, by sex || 
|-
| HFAMDB_34 || Accidental poisoning by alcohol, number of deaths, by sex || 
|-
| HFAMDB_35 || Accidental poisoning by alcohol, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_36 || Accidental poisoning by alcohol, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_37 || Accidental poisoning by alcohol, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_38 || Accidental poisoning by alcohol, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_39 || Accidental poisoning by alcohol, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_40 || Accidental poisoning by alcohol, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_41 || Accidental poisoning by alcohol, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_42 || Accidental poisoning by alcohol, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_43 || Accidental poisoning by alcohol, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_44 || Accidental poisoning by alcohol, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_45 || Accidental poisoning, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_46 || Accidental poisoning, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_47 || Accidental poisoning, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_48 || Accidental poisoning, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_49 || Accidental poisoning, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_50 || Accidental poisoning, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_51 || Accidental poisoning, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_52 || Accidental poisoning, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_53 || Accidental poisoning, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_54 || Accidental poisoning, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_55 || Accidental poisoning, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_56 || Accidental poisoning, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_57 || Accidental poisoning, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_58 || Accidental poisoning, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_59 || Accidental poisoning, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_60 || Accidents, number of deaths, by sex || 
|-
| HFAMDB_61 || Accidents, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_62 || Accidents, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_63 || Accidents, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_64 || Accidents, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_65 || Accidents, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_66 || Accidents, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_67 || Accidents, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_68 || Accidents, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_69 || Accidents, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_70 || Accidents, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_71 || Accidents, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_72 || Accidents, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_73 || Accidents, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_74 || Accidents, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_75 || Accidents, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_76 || AIDS/HIV (as recorded by routine mortality statistics system), number of deaths, by sex || 
|-
| HFAMDB_77 || AIDS/HIV (as recorded by routine mortality statistics system), 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_78 || AIDS/HIV (as recorded by routine mortality statistics system), 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_79 || AIDS/HIV (as recorded by routine mortality statistics system), 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_80 || AIDS/HIV (as recorded by routine mortality statistics system), 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_81 || AIDS/HIV (as recorded by routine mortality statistics system), 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_82 || AIDS/HIV (as recorded by routine mortality statistics system), 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_83 || AIDS/HIV (as recorded by routine mortality statistics system), 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_84 || AIDS/HIV (as recorded by routine mortality statistics system), 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_85 || AIDS/HIV (as recorded by routine mortality statistics system), 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_86 || AIDS/HIV (as recorded by routine mortality statistics system),as recorded by routine mortality statistics system per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_87 || Alcohol abuse (including alcoholic psychosis), number of deaths, by sex || 
|-
| HFAMDB_88 || Alcohol abuse (including alcoholic psychosis), 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_89 || Alcohol abuse (including alcoholic psychosis), 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_90 || Alcohol abuse (including alcoholic psychosis), 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_91 || Alcohol abuse (including alcoholic psychosis), 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_92 || Alcohol abuse (including alcoholic psychosis), 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_93 || Alcohol abuse (including alcoholic psychosis), 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_94 || Alcohol abuse (including alcoholic psychosis), 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_95 || Alcohol abuse (including alcoholic psychosis), 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_96 || Alcohol abuse (including alcoholic psychosis), 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_97 || Alcohol abuse (including alcoholic psychosis),including alcoholic psychosis per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_98 || All causes, number of deaths, by sex || 
|-
| HFAMDB_99 || All causes, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_100 || All causes, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_101 || All causes, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_102 || All causes, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_103 || All causes, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_104 || All causes, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_105 || All causes, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_106 || All causes, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_107 || All causes, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_108 || All causes, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_109 || All causes, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_110 || All causes, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_111 || All causes, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_112 || All causes, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_113 || All causes, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_114 || Alzheimer's disease and other degenerative diseases of nervous system, number of deaths, by sex || 
|-
| HFAMDB_115 || Alzheimer's disease and other degenerative diseases of nervous system, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_116 || Alzheimer's disease and other degenerative diseases of nervous system, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_117 || Alzheimer's disease and other degenerative diseases of nervous system, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_118 || Alzheimer's disease and other degenerative diseases of nervous system, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_119 || Alzheimer's disease and other degenerative diseases of nervous system, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_120 || Alzheimer's disease and other degenerative diseases of nervous system, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_121 || Alzheimer's disease and other degenerative diseases of nervous system, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_122 || Alzheimer's disease and other degenerative diseases of nervous system, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_123 || Alzheimer's disease and other degenerative diseases of nervous system, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_124 || Alzheimer's disease and other degenerative diseases of nervous system, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_125 || Asthma, number of deaths, by sex || 
|-
| HFAMDB_126 || Asthma, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_127 || Asthma, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_128 || Asthma, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_129 || Asthma, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_130 || Asthma, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_131 || Asthma, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_132 || Asthma, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_133 || Asthma, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_134 || Asthma, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_135 || Asthma, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_136 || Cerebrovascular diseases, number of deaths, by sex || 
|-
| HFAMDB_137 || Cerebrovascular diseases, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_138 || Cerebrovascular diseases, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_139 || Cerebrovascular diseases, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_140 || Cerebrovascular diseases, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_141 || Cerebrovascular diseases, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_142 || Cerebrovascular diseases, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_143 || Cerebrovascular diseases, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_144 || Cerebrovascular diseases, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_145 || Cerebrovascular diseases, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_146 || Cerebrovascular diseases, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_147 || Certain conditions originating in the perinatal period, number of deaths, by sex || 
|-
| HFAMDB_148 || Certain conditions originating in the perinatal period, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_149 || Chronic liver disease and cirrhosis, number of deaths, by sex || 
|-
| HFAMDB_150 || Chronic liver disease and cirrhosis, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_151 || Chronic liver disease and cirrhosis, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_152 || Chronic liver disease and cirrhosis, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_153 || Chronic liver disease and cirrhosis, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_154 || Chronic liver disease and cirrhosis, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_155 || Chronic liver disease and cirrhosis, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_156 || Chronic liver disease and cirrhosis, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_157 || Chronic liver disease and cirrhosis, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_158 || Chronic liver disease and cirrhosis, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_159 || Chronic liver disease and cirrhosis, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_160 || Chronic lower respiratory diseases, number of deaths, by sex || 
|-
| HFAMDB_161 || Chronic lower respiratory diseases, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_162 || Chronic lower respiratory diseases, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_163 || Chronic lower respiratory diseases, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_164 || Chronic lower respiratory diseases, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_165 || Chronic lower respiratory diseases, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_166 || Chronic lower respiratory diseases, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_167 || Chronic lower respiratory diseases, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_168 || Chronic lower respiratory diseases, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_169 || Chronic lower respiratory diseases, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_170 || Chronic lower respiratory diseases, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_171 || Complications of pregnancy, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_172 || Complications of pregnancy, childbirth and puerperium, females, number of deaths || 
|-
| HFAMDB_173 || Congenital malformations and chromosomal abnormalities, number of deaths, by sex || 
|-
| HFAMDB_174 || Congenital malformations and chromosomal abnormalities, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_175 || Congenital malformations and chromosomal abnormalities, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_176 || Congenital malformations and chromosomal abnormalities, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_177 || Congenital malformations and chromosomal abnormalities, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_178 || Congenital malformations and chromosomal abnormalities, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_179 || Congenital malformations and chromosomal abnormalities, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_180 || Congenital malformations and chromosomal abnormalities, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_181 || Congenital malformations and chromosomal abnormalities, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_182 || Congenital malformations and chromosomal abnormalities, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_183 || Congenital malformations and chromosomal abnormalities, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_184 || Congenital malformations and chromosomal abnormalities, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_185 || Congenital malformations and chromosomal abnormalities, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_186 || Congenital malformations and chromosomal abnormalities, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_187 || Congenital malformations and chromosomal abnormalities, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_188 || Congenital malformations and chromosomal abnormalities, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_189 || Diabetes mellitus, number of deaths, by sex || 
|-
| HFAMDB_190 || Diabetes mellitus, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_191 || Diabetes mellitus, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_192 || Diabetes mellitus, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_193 || Diabetes mellitus, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_194 || Diabetes mellitus, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_195 || Diabetes mellitus, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_196 || Diabetes mellitus, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_197 || Diabetes mellitus, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_198 || Diabetes mellitus, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_199 || Diabetes mellitus, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_200 || Diseases of genitourinary system, number of deaths, by sex || 
|-
| HFAMDB_201 || Diseases of genitourinary system, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_202 || Diseases of genitourinary system, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_203 || Diseases of genitourinary system, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_204 || Diseases of genitourinary system, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_205 || Diseases of genitourinary system, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_206 || Diseases of genitourinary system, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_207 || Diseases of genitourinary system, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_208 || Diseases of genitourinary system, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_209 || Diseases of genitourinary system, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_210 || Diseases of genitourinary system, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_211 || Diseases of musculoskeletal system and connective tissue, number of deaths, by sex || 
|-
| HFAMDB_212 || Diseases of musculoskeletal system and connective tissue, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_213 || Diseases of musculoskeletal system and connective tissue, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_214 || Diseases of musculoskeletal system and connective tissue, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_215 || Diseases of musculoskeletal system and connective tissue, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_216 || Diseases of musculoskeletal system and connective tissue, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_217 || Diseases of musculoskeletal system and connective tissue, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_218 || Diseases of musculoskeletal system and connective tissue, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_219 || Diseases of musculoskeletal system and connective tissue, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_220 || Diseases of musculoskeletal system and connective tissue, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_221 || Diseases of musculoskeletal system and connective tissue, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_222 || Diseases of nervous system and sense organs, number of deaths, by sex || 
|-
| HFAMDB_223 || Diseases of nervous system and sense organs, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_224 || Diseases of nervous system and sense organs, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_225 || Diseases of nervous system and sense organs, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_226 || Diseases of nervous system and sense organs, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_227 || Diseases of nervous system and sense organs, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_228 || Diseases of nervous system and sense organs, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_229 || Diseases of nervous system and sense organs, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_230 || Diseases of nervous system and sense organs, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_231 || Diseases of nervous system and sense organs, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_232 || Diseases of nervous system and sense organs, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_233 || Diseases of skin and subcutaneous tissue, number of deaths, by sex || 
|-
| HFAMDB_234 || Diseases of skin and subcutaneous tissue, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_235 || Diseases of skin and subcutaneous tissue, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_236 || Diseases of skin and subcutaneous tissue, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_237 || Diseases of skin and subcutaneous tissue, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_238 || Diseases of skin and subcutaneous tissue, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_239 || Diseases of skin and subcutaneous tissue, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_240 || Diseases of skin and subcutaneous tissue, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_241 || Diseases of skin and subcutaneous tissue, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_242 || Diseases of skin and subcutaneous tissue, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_243 || Diseases of skin and subcutaneous tissue, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_244 || Diseases of the blood, blood forming organs and certain immunity disorders, number of deaths, by sex || 
|-
| HFAMDB_245 || Diseases of the blood, blood forming organs and certain immunity disorders, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_246 || Diseases of the blood, blood forming organs and certain immunity disorders, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_247 || Diseases of the blood, blood forming organs and certain immunity disorders, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_248 || Diseases of the blood, blood forming organs and certain immunity disorders, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_249 || Diseases of the blood, blood forming organs and certain immunity disorders, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_250 || Diseases of the blood, blood forming organs and certain immunity disorders, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_251 || Diseases of the blood, blood forming organs and certain immunity disorders, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_252 || Diseases of the blood, blood forming organs and certain immunity disorders, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_253 || Diseases of the blood, blood forming organs and certain immunity disorders, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_254 || Diseases of the blood, blood forming organs and certain immunity disorders, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_255 || Diseases of the blood, blood forming organs and certain immunity disorders, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_256 || Diseases of the blood, blood forming organs and certain immunity disorders, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_257 || Diseases of the blood, blood forming organs and certain immunity disorders, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_258 || Diseases of the blood, blood forming organs and certain immunity disorders, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_259 || Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_260 || Diseases of the circulatory system, number of deaths, by sex || 
|-
| HFAMDB_261 || Diseases of the circulatory system, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_262 || Diseases of the circulatory system, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_263 || Diseases of the circulatory system, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_264 || Diseases of the circulatory system, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_265 || Diseases of the circulatory system, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_266 || Diseases of the circulatory system, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_267 || Diseases of the circulatory system, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_268 || Diseases of the circulatory system, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_269 || Diseases of the circulatory system, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_270 || Diseases of the circulatory system, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_271 || Diseases of the circulatory system, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_272 || Diseases of the circulatory system, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_273 || Diseases of the circulatory system, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_274 || Diseases of the circulatory system, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_275 || Diseases of the circulatory system, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_276 || Diseases of the digestive system, number of deaths, by sex || 
|-
| HFAMDB_277 || Diseases of the digestive system, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_278 || Diseases of the digestive system, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_279 || Diseases of the digestive system, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_280 || Diseases of the digestive system, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_281 || Diseases of the digestive system, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_282 || Diseases of the digestive system, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_283 || Diseases of the digestive system, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_284 || Diseases of the digestive system, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_285 || Diseases of the digestive system, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_286 || Diseases of the digestive system, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_287 || Diseases of the digestive system, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_288 || Diseases of the digestive system, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_289 || Diseases of the digestive system, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_290 || Diseases of the digestive system, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_291 || Diseases of the digestive system, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_292 || Diseases of the respiratory system, number of deaths, by sex || 
|-
| HFAMDB_293 || Diseases of the respiratory system, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_294 || Diseases of the respiratory system, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_295 || Diseases of the respiratory system, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_296 || Diseases of the respiratory system, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_297 || Diseases of the respiratory system, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_298 || Diseases of the respiratory system, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_299 || Diseases of the respiratory system, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_300 || Diseases of the respiratory system, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_301 || Diseases of the respiratory system, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_302 || Diseases of the respiratory system, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_303 || Diseases of the respiratory system, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_304 || Diseases of the respiratory system, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_305 || Diseases of the respiratory system, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_306 || Diseases of the respiratory system, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_307 || Diseases of the respiratory system, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_308 || Drug dependence and toxicomania, number of deaths, by sex || 
|-
| HFAMDB_309 || Drug dependence and toxicomania, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_310 || Drug dependence and toxicomania, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_311 || Drug dependence and toxicomania, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_312 || Drug dependence and toxicomania, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_313 || Drug dependence and toxicomania, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_314 || Drug dependence and toxicomania, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_315 || Drug dependence and toxicomania, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_316 || Drug dependence and toxicomania, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_317 || Drug dependence and toxicomania, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_318 || Drug dependence and toxicomania, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_319 || Endocrine, nutritional and metabolic diseases, number of deaths, by sex || 
|-
| HFAMDB_320 || Endocrine, nutritional and metabolic diseases, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_321 || Endocrine, nutritional and metabolic diseases, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_322 || Endocrine, nutritional and metabolic diseases, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_323 || Endocrine, nutritional and metabolic diseases, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_324 || Endocrine, nutritional and metabolic diseases, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_325 || Endocrine, nutritional and metabolic diseases, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_326 || Endocrine, nutritional and metabolic diseases, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_327 || Endocrine, nutritional and metabolic diseases, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_328 || Endocrine, nutritional and metabolic diseases, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_329 || Endocrine, nutritional and metabolic diseases, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_330 || Endocrine, nutritional and metabolic diseases, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_331 || Endocrine, nutritional and metabolic diseases, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_332 || Endocrine, nutritional and metabolic diseases, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_333 || Endocrine, nutritional and metabolic diseases, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_334 || Endocrine, nutritional and metabolic diseases, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_335 || Events of undetermined intent, number of deaths, by sex || 
|-
| HFAMDB_336 || Events of undetermined intent, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_337 || Events of undetermined intent, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_338 || Events of undetermined intent, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_339 || Events of undetermined intent, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_340 || Events of undetermined intent, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_341 || Events of undetermined intent, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_342 || Events of undetermined intent, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_343 || Events of undetermined intent, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_344 || Events of undetermined intent, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_345 || Events of undetermined intent, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_346 || Exposure to smoke, fire and flames, number of deaths, by sex || 
|-
| HFAMDB_347 || Exposure to smoke, fire and flames, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_348 || Exposure to smoke, fire and flames, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_349 || Exposure to smoke, fire and flames, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_350 || Exposure to smoke, fire and flames, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_351 || Exposure to smoke, fire and flames, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_352 || Exposure to smoke, fire and flames, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_353 || Exposure to smoke, fire and flames, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_354 || Exposure to smoke, fire and flames, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_355 || Exposure to smoke, fire and flames, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_356 || Exposure to smoke, fire and flames, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_357 || Exposure to smoke, fire and flames, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_358 || Exposure to smoke, fire and flames, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_359 || Exposure to smoke, fire and flames, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_360 || Exposure to smoke, fire and flames, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_361 || Exposure to smoke, fire and flames, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_362 || External causes of injury and poisoning, number of deaths, by sex || 
|-
| HFAMDB_363 || External causes of injury and poisoning, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_364 || External causes of injury and poisoning, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_365 || External causes of injury and poisoning, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_366 || External causes of injury and poisoning, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_367 || External causes of injury and poisoning, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_368 || External causes of injury and poisoning, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_369 || External causes of injury and poisoning, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_370 || External causes of injury and poisoning, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_371 || External causes of injury and poisoning, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_372 || External causes of injury and poisoning, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_373 || External causes of injury and poisoning, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_374 || External causes of injury and poisoning, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_375 || External causes of injury and poisoning, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_376 || External causes of injury and poisoning, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_377 || External causes of injury and poisoning, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_378 || Homicide and assault, number of deaths, by sex || 
|-
| HFAMDB_379 || Homicide and assault, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_380 || Homicide and assault, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_381 || Homicide and assault, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_382 || Homicide and assault, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_383 || Homicide and assault, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_384 || Homicide and assault, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_385 || Homicide and assault, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_386 || Homicide and assault, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_387 || Homicide and assault, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_388 || Homicide and assault, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_389 || Infectious and parasitic diseases, number of deaths, by sex || 
|-
| HFAMDB_390 || Infectious and parasitic diseases, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_391 || Infectious and parasitic diseases, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_392 || Infectious and parasitic diseases, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_393 || Infectious and parasitic diseases, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_394 || Infectious and parasitic diseases, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_395 || Infectious and parasitic diseases, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_396 || Infectious and parasitic diseases, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_397 || Infectious and parasitic diseases, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_398 || Infectious and parasitic diseases, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_399 || Infectious and parasitic diseases, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_400 || Infectious and parasitic diseases, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_401 || Infectious and parasitic diseases, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_402 || Infectious and parasitic diseases, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_403 || Infectious and parasitic diseases, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_404 || Infectious and parasitic diseases, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_405 || Influenza, number of deaths, by sex || 
|-
| HFAMDB_406 || Influenza, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_407 || Influenza, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_408 || Influenza, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_409 || Influenza, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_410 || Influenza, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_411 || Influenza, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_412 || Influenza, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_413 || Influenza, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_414 || Influenza, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_415 || Influenza, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_416 || Intestinal infectious diseases, number of deaths, by sex || 
|-
| HFAMDB_417 || Intestinal infectious diseases, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_418 || Intestinal infectious diseases, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_419 || Intestinal infectious diseases, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_420 || Intestinal infectious diseases, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_421 || Intestinal infectious diseases, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_422 || Intestinal infectious diseases, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_423 || Intestinal infectious diseases, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_424 || Intestinal infectious diseases, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_425 || Intestinal infectious diseases, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_426 || Intestinal infectious diseases, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_427 || Ischaemic heart disease, number of deaths, by sex || 
|-
| HFAMDB_428 || Ischaemic heart disease, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_429 || Ischaemic heart disease, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_430 || Ischaemic heart disease, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_431 || Ischaemic heart disease, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_432 || Ischaemic heart disease, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_433 || Ischaemic heart disease, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_434 || Ischaemic heart disease, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_435 || Ischaemic heart disease, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_436 || Ischaemic heart disease, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_437 || Ischaemic heart disease, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_438 || Malignant melanoma of skin, number of deaths, by sex || 
|-
| HFAMDB_439 || Malignant melanoma of skin, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_440 || Malignant melanoma of skin, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_441 || Malignant melanoma of skin, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_442 || Malignant melanoma of skin, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_443 || Malignant melanoma of skin, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_444 || Malignant melanoma of skin, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_445 || Malignant melanoma of skin, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_446 || Malignant melanoma of skin, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_447 || Malignant melanoma of skin, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_448 || Malignant melanoma of skin, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_449 || Malignant neoplasm of bladder, number of deaths, by sex || 
|-
| HFAMDB_450 || Malignant neoplasm of bladder, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_451 || Malignant neoplasm of bladder, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_452 || Malignant neoplasm of bladder, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_453 || Malignant neoplasm of bladder, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_454 || Malignant neoplasm of bladder, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_455 || Malignant neoplasm of bladder, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_456 || Malignant neoplasm of bladder, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_457 || Malignant neoplasm of bladder, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_458 || Malignant neoplasm of bladder, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_459 || Malignant neoplasm of bladder, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_460 || Malignant neoplasm of breast, number of deaths, by sex || 
|-
| HFAMDB_461 || Malignant neoplasm of breast, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_462 || Malignant neoplasm of breast, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_463 || Malignant neoplasm of breast, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_464 || Malignant neoplasm of breast, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_465 || Malignant neoplasm of breast, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_466 || Malignant neoplasm of breast, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_467 || Malignant neoplasm of breast, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_468 || Malignant neoplasm of breast, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_469 || Malignant neoplasm of breast, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_470 || Malignant neoplasm of breast, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_471 || Malignant neoplasm of cervix uteri, females, number of deaths || 
|-
| HFAMDB_472 || Malignant neoplasm of cervix uteri, 0-14 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_473 || Malignant neoplasm of cervix uteri, 0-64 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_474 || Malignant neoplasm of cervix uteri, 15-29 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_475 || Malignant neoplasm of cervix uteri, 25-64 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_476 || Malignant neoplasm of cervix uteri, 30-44 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_477 || Malignant neoplasm of cervix uteri, 45-59 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_478 || Malignant neoplasm of cervix uteri, 60-74 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_479 || Malignant neoplasm of cervix uteri, 65+ years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_480 || Malignant neoplasm of cervix uteri, 75+ years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_481 || Malignant neoplasm of cervix uteri, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_482 || Malignant neoplasm of colon, rectum and anus, number of deaths, by sex || 
|-
| HFAMDB_483 || Malignant neoplasm of colon, rectum and anus, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_484 || Malignant neoplasm of colon, rectum and anus, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_485 || Malignant neoplasm of colon, rectum and anus, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_486 || Malignant neoplasm of colon, rectum and anus, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_487 || Malignant neoplasm of colon, rectum and anus, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_488 || Malignant neoplasm of colon, rectum and anus, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_489 || Malignant neoplasm of colon, rectum and anus, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_490 || Malignant neoplasm of colon, rectum and anus, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_491 || Malignant neoplasm of colon, rectum and anus, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_492 || Malignant neoplasm of colon, rectum and anus, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_493 || Malignant neoplasm of esophagus, number of deaths, by sex || 
|-
| HFAMDB_494 || Malignant neoplasm of esophagus, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_495 || Malignant neoplasm of esophagus, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_496 || Malignant neoplasm of esophagus, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_497 || Malignant neoplasm of esophagus, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_498 || Malignant neoplasm of esophagus, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_499 || Malignant neoplasm of esophagus, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_500 || Malignant neoplasm of esophagus, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_501 || Malignant neoplasm of esophagus, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_502 || Malignant neoplasm of esophagus, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_503 || Malignant neoplasm of esophagus, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_504 || Malignant neoplasm of larynx, trachea, bronchus and lung, number of deaths, by sex || 
|-
| HFAMDB_505 || Malignant neoplasm of larynx, trachea, bronchus and lung, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_506 || Malignant neoplasm of larynx, trachea, bronchus and lung, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_507 || Malignant neoplasm of larynx, trachea, bronchus and lung, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_508 || Malignant neoplasm of larynx, trachea, bronchus and lung, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_509 || Malignant neoplasm of larynx, trachea, bronchus and lung, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_510 || Malignant neoplasm of larynx, trachea, bronchus and lung, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_511 || Malignant neoplasm of larynx, trachea, bronchus and lung, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_512 || Malignant neoplasm of larynx, trachea, bronchus and lung, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_513 || Malignant neoplasm of larynx, trachea, bronchus and lung, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_514 || Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_515 || Malignant neoplasm of lip/oral cavity/pharynx, number of deaths, by sex || 
|-
| HFAMDB_516 || Malignant neoplasm of lip/oral cavity/pharynx, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_517 || Malignant neoplasm of lip/oral cavity/pharynx, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_518 || Malignant neoplasm of lip/oral cavity/pharynx, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_519 || Malignant neoplasm of lip/oral cavity/pharynx, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_520 || Malignant neoplasm of lip/oral cavity/pharynx, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_521 || Malignant neoplasm of lip/oral cavity/pharynx, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_522 || Malignant neoplasm of lip/oral cavity/pharynx, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_523 || Malignant neoplasm of lip/oral cavity/pharynx, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_524 || Malignant neoplasm of lip/oral cavity/pharynx, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_525 || Malignant neoplasm of lip/oral cavity/pharynx, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_526 || Malignant neoplasm of liver and intrahepatic bile ducts, number of deaths, by sex || 
|-
| HFAMDB_527 || Malignant neoplasm of liver and intrahepatic bile ducts, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_528 || Malignant neoplasm of liver and intrahepatic bile ducts, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_529 || Malignant neoplasm of liver and intrahepatic bile ducts, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_530 || Malignant neoplasm of liver and intrahepatic bile ducts, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_531 || Malignant neoplasm of liver and intrahepatic bile ducts, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_532 || Malignant neoplasm of liver and intrahepatic bile ducts, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_533 || Malignant neoplasm of liver and intrahepatic bile ducts, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_534 || Malignant neoplasm of liver and intrahepatic bile ducts, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_535 || Malignant neoplasm of liver and intrahepatic bile ducts, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_536 || Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_537 || Malignant neoplasm of lymphoid and haematopoietic tissue, number of deaths, by sex || 
|-
| HFAMDB_538 || Malignant neoplasm of lymphoid and haematopoietic tissue, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_539 || Malignant neoplasm of lymphoid and haematopoietic tissue, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_540 || Malignant neoplasm of lymphoid and haematopoietic tissue, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_541 || Malignant neoplasm of lymphoid and haematopoietic tissue, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_542 || Malignant neoplasm of lymphoid and haematopoietic tissue, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_543 || Malignant neoplasm of lymphoid and haematopoietic tissue, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_544 || Malignant neoplasm of lymphoid and haematopoietic tissue, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_545 || Malignant neoplasm of lymphoid and haematopoietic tissue, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_546 || Malignant neoplasm of lymphoid and haematopoietic tissue, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_547 || Malignant neoplasm of lymphoid and haematopoietic tissue, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_548 || Malignant neoplasm of lymphoid and haematopoietic tissue, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_549 || Malignant neoplasm of lymphoid and haematopoietic tissue, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_550 || Malignant neoplasm of lymphoid and haematopoietic tissue, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_551 || Malignant neoplasm of lymphoid and haematopoietic tissue, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_552 || Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_553 || Malignant neoplasm of other parts of uterus, females, number of deaths || 
|-
| HFAMDB_554 || Malignant neoplasm of other parts of uterus, 0-14 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_555 || Malignant neoplasm of other parts of uterus, 0-64 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_556 || Malignant neoplasm of other parts of uterus, 15-29 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_557 || Malignant neoplasm of other parts of uterus, 25-64 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_558 || Malignant neoplasm of other parts of uterus, 30-44 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_559 || Malignant neoplasm of other parts of uterus, 45-59 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_560 || Malignant neoplasm of other parts of uterus, 60-74 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_561 || Malignant neoplasm of other parts of uterus, 65+ years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_562 || Malignant neoplasm of other parts of uterus, 75+ years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_563 || Malignant neoplasm of other parts of uterus, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_564 || Malignant neoplasm of ovary, females, number of deaths || 
|-
| HFAMDB_565 || Malignant neoplasm of ovary, 0-14 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_566 || Malignant neoplasm of ovary, 0-64 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_567 || Malignant neoplasm of ovary, 15-29 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_568 || Malignant neoplasm of ovary, 25-64 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_569 || Malignant neoplasm of ovary, 30-44 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_570 || Malignant neoplasm of ovary, 45-59 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_571 || Malignant neoplasm of ovary, 60-74 years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_572 || Malignant neoplasm of ovary, 65+ years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_573 || Malignant neoplasm of ovary, 75+ years, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_574 || Malignant neoplasm of ovary, per 100 000 population, females (age-standardized death rate) || 
|-
| HFAMDB_575 || Malignant neoplasm of prostate, males, number of deaths || 
|-
| HFAMDB_576 || Malignant neoplasm of prostate, 0-14 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_577 || Malignant neoplasm of prostate, 0-64 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_578 || Malignant neoplasm of prostate, 15-29 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_579 || Malignant neoplasm of prostate, 25-64 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_580 || Malignant neoplasm of prostate, 30-44 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_581 || Malignant neoplasm of prostate, 45-59 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_582 || Malignant neoplasm of prostate, 60-74 years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_583 || Malignant neoplasm of prostate, 65+ years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_584 || Malignant neoplasm of prostate, 75+ years, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_585 || Malignant neoplasm of prostate, per 100 000 population, males (age-standardized death rate) || 
|-
| HFAMDB_586 || Malignant neoplasm of pancreas, number of deaths, by sex || 
|-
| HFAMDB_587 || Malignant neoplasm of pancreas, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_588 || Malignant neoplasm of pancreas, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_589 || Malignant neoplasm of pancreas, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_590 || Malignant neoplasm of pancreas, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_591 || Malignant neoplasm of pancreas, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_592 || Malignant neoplasm of pancreas, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_593 || Malignant neoplasm of pancreas, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_594 || Malignant neoplasm of pancreas, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_595 || Malignant neoplasm of pancreas, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_596 || Malignant neoplasm of pancreas, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_597 || Malignant neoplasm of stomach, number of deaths, by sex || 
|-
| HFAMDB_598 || Malignant neoplasm of stomach, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_599 || Malignant neoplasm of stomach, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_600 || Malignant neoplasm of stomach, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_601 || Malignant neoplasm of stomach, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_602 || Malignant neoplasm of stomach, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_603 || Malignant neoplasm of stomach, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_604 || Malignant neoplasm of stomach, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_605 || Malignant neoplasm of stomach, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_606 || Malignant neoplasm of stomach, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_607 || Malignant neoplasm of stomach, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_608 || Malignant neoplasm of trachea, bronchus and lung, number of deaths, by sex || 
|-
| HFAMDB_609 || Malignant neoplasm of trachea, bronchus and lung, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_610 || Malignant neoplasm of trachea, bronchus and lung, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_611 || Malignant neoplasm of trachea, bronchus and lung, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_612 || Malignant neoplasm of trachea, bronchus and lung, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_613 || Malignant neoplasm of trachea, bronchus and lung, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_614 || Malignant neoplasm of trachea, bronchus and lung, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_615 || Malignant neoplasm of trachea, bronchus and lung, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_616 || Malignant neoplasm of trachea, bronchus and lung, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_617 || Malignant neoplasm of trachea, bronchus and lung, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_618 || Malignant neoplasm of trachea, bronchus and lung, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_619 || Malignant neoplasms, number of deaths, by sex || 
|-
| HFAMDB_620 || Malignant neoplasms, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_621 || Malignant neoplasms, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_622 || Malignant neoplasms, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_623 || Malignant neoplasms, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_624 || Malignant neoplasms, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_625 || Malignant neoplasms, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_626 || Malignant neoplasms, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_627 || Malignant neoplasms, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_628 || Malignant neoplasms, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_629 || Malignant neoplasms, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_630 || Malignant neoplasms, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_631 || Malignant neoplasms, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_632 || Malignant neoplasms, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_633 || Malignant neoplasms, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_634 || Malignant neoplasms, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_635 || Meningitis, number of deaths, by sex || 
|-
| HFAMDB_636 || Meningitis, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_637 || Meningitis, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_638 || Meningitis, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_639 || Meningitis, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_640 || Meningitis, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_641 || Meningitis, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_642 || Meningitis, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_643 || Meningitis, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_644 || Meningitis, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_645 || Meningitis, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_646 || Meningococcal infection, number of deaths, by sex || 
|-
| HFAMDB_647 || Meningococcal infection, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_648 || Meningococcal infection, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_649 || Meningococcal infection, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_650 || Meningococcal infection, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_651 || Meningococcal infection, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_652 || Meningococcal infection, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_653 || Meningococcal infection, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_654 || Meningococcal infection, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_655 || Meningococcal infection, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_656 || Meningococcal infection, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_657 || Mental and behavioural disorders, number of deaths, by sex || 
|-
| HFAMDB_658 || Mental and behavioural disorders, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_659 || Mental and behavioural disorders, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_660 || Mental and behavioural disorders, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_661 || Mental and behavioural disorders, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_662 || Mental and behavioural disorders, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_663 || Mental and behavioural disorders, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_664 || Mental and behavioural disorders, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_665 || Mental and behavioural disorders, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_666 || Mental and behavioural disorders, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_667 || Mental and behavioural disorders, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_668 || Motor vehicle traffic accidents, number of deaths, by sex || 
|-
| HFAMDB_669 || Motor vehicle traffic accidents, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_670 || Motor vehicle traffic accidents, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_671 || Motor vehicle traffic accidents, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_672 || Motor vehicle traffic accidents, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_673 || Motor vehicle traffic accidents, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_674 || Motor vehicle traffic accidents, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_675 || Motor vehicle traffic accidents, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_676 || Motor vehicle traffic accidents, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_677 || Motor vehicle traffic accidents, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_678 || Motor vehicle traffic accidents, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_679 || Motor vehicle traffic accidents, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_680 || Motor vehicle traffic accidents, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_681 || Motor vehicle traffic accidents, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_682 || Motor vehicle traffic accidents, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_683 || Motor vehicle traffic accidents, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_684 || Neoplasms, number of deaths, by sex || 
|-
| HFAMDB_685 || Neoplasms, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_686 || Neoplasms, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_687 || Neoplasms, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_688 || Neoplasms, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_689 || Neoplasms, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_690 || Neoplasms, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_691 || Neoplasms, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_692 || Neoplasms, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_693 || Neoplasms, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_694 || Neoplasms, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_695 || Neoplasms, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_696 || Neoplasms, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_697 || Neoplasms, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_698 || Neoplasms, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_699 || Neoplasms, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_700 || Other acute respiratory infections, number of deaths, by sex || 
|-
| HFAMDB_701 || Other acute respiratory infections, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_702 || Other acute respiratory infections, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_703 || Other acute respiratory infections, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_704 || Other acute respiratory infections, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_705 || Other acute respiratory infections, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_706 || Other acute respiratory infections, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_707 || Other acute respiratory infections, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_708 || Other acute respiratory infections, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_709 || Other acute respiratory infections, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_710 || Other acute respiratory infections, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_711 || Pneumonia, number of deaths, by sex || 
|-
| HFAMDB_712 || Pneumonia, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_713 || Pneumonia, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_714 || Pneumonia, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_715 || Pneumonia, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_716 || Pneumonia, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_717 || Pneumonia, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_718 || Pneumonia, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_719 || Pneumonia, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_720 || Pneumonia, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_721 || Pneumonia, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_722 || Pneumonia, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_723 || Pneumonia, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_724 || Pneumonia, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_725 || Pneumonia, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_726 || Pneumonia, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_727 || Psychoactive substance use, number of deaths, by sex || 
|-
| HFAMDB_728 || Psychoactive substance use, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_729 || Psychoactive substance use, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_730 || Psychoactive substance use, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_731 || Psychoactive substance use, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_732 || Psychoactive substance use, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_733 || Psychoactive substance use, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_734 || Psychoactive substance use, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_735 || Psychoactive substance use, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_736 || Psychoactive substance use, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_737 || Psychoactive substance use, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_738 || Pulmonary heart disease and other heart diseases, number of deaths, by sex || 
|-
| HFAMDB_739 || Pulmonary heart disease and other heart diseases, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_740 || Pulmonary heart disease and other heart diseases, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_741 || Pulmonary heart disease and other heart diseases, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_742 || Pulmonary heart disease and other heart diseases, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_743 || Pulmonary heart disease and other heart diseases, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_744 || Pulmonary heart disease and other heart diseases, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_745 || Pulmonary heart disease and other heart diseases, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_746 || Pulmonary heart disease and other heart diseases, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_747 || Pulmonary heart disease and other heart diseases, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_748 || Pulmonary heart disease and other heart diseases, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_749 || Sudden and unattended death, cause unknown, number of deaths, by sex || 
|-
| HFAMDB_750 || Sudden and unattended death, cause unknown, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_751 || Sudden and unattended death, cause unknown, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_752 || Sudden and unattended death, cause unknown, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_753 || Sudden and unattended death, cause unknown, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_754 || Sudden and unattended death, cause unknown, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_755 || Sudden and unattended death, cause unknown, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_756 || Sudden and unattended death, cause unknown, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_757 || Sudden and unattended death, cause unknown, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_758 || Sudden and unattended death, cause unknown, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_759 || Sudden and unattended death, cause unknown, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_760 || Sudden and unattended death, cause unknown, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_761 || Suicide and intentional self-harm, number of deaths, by sex || 
|-
| HFAMDB_762 || Suicide and intentional self-harm, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_763 || Suicide and intentional self-harm, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_764 || Suicide and intentional self-harm, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_765 || Suicide and intentional self-harm, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_766 || Suicide and intentional self-harm, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_767 || Suicide and intentional self-harm, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_768 || Suicide and intentional self-harm, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_769 || Suicide and intentional self-harm, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_770 || Suicide and intentional self-harm, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_771 || Suicide and intentional self-harm, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_772 || Symptoms, signs, abnormal findings, ill-defined causes, number of deaths, by sex || 
|-
| HFAMDB_773 || Symptoms, signs, abnormal findings, ill-defined causes, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_774 || Symptoms, signs, abnormal findings, ill-defined causes, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_775 || Symptoms, signs, abnormal findings, ill-defined causes, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_776 || Symptoms, signs, abnormal findings, ill-defined causes, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_777 || Symptoms, signs, abnormal findings, ill-defined causes, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_778 || Symptoms, signs, abnormal findings, ill-defined causes, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_779 || Symptoms, signs, abnormal findings, ill-defined causes, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_780 || Symptoms, signs, abnormal findings, ill-defined causes, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_781 || Symptoms, signs, abnormal findings, ill-defined causes, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_782 || Symptoms, signs, abnormal findings, ill-defined causes, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_783 || Transport accidents, number of deaths, by sex || 
|-
| HFAMDB_784 || Transport accidents, 0 year, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_785 || Transport accidents, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_786 || Transport accidents, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_787 || Transport accidents, 1-19 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_788 || Transport accidents, 1-4 years, per 100 000 population, by sex (crude death rate) || 
|-
| HFAMDB_789 || Transport accidents, 15-24 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_790 || Transport accidents, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_791 || Transport accidents, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_792 || Transport accidents, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_793 || Transport accidents, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_794 || Transport accidents, 5-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_795 || Transport accidents, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_796 || Transport accidents, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_797 || Transport accidents, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_798 || Transport accidents, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_799 || Tuberculosis, number of deaths, by sex || 
|-
| HFAMDB_800 || Tuberculosis, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_801 || Tuberculosis, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_802 || Tuberculosis, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_803 || Tuberculosis, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_804 || Tuberculosis, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_805 || Tuberculosis, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_806 || Tuberculosis, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_807 || Tuberculosis, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_808 || Tuberculosis, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_809 || Tuberculosis, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_810 || Ulcer of stomach and duodenum, number of deaths, by sex || 
|-
| HFAMDB_811 || Ulcer of stomach and duodenum, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_812 || Ulcer of stomach and duodenum, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_813 || Ulcer of stomach and duodenum, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_814 || Ulcer of stomach and duodenum, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_815 || Ulcer of stomach and duodenum, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_816 || Ulcer of stomach and duodenum, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_817 || Ulcer of stomach and duodenum, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_818 || Ulcer of stomach and duodenum, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_819 || Ulcer of stomach and duodenum, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_820 || Ulcer of stomach and duodenum, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_821 || Viral hepatitis, number of deaths, by sex || 
|-
| HFAMDB_822 || Viral hepatitis, 0-14 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_823 || Viral hepatitis, 0-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_824 || Viral hepatitis, 15-29 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_825 || Viral hepatitis, 25-64 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_826 || Viral hepatitis, 30-44 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_827 || Viral hepatitis, 45-59 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_828 || Viral hepatitis, 60-74 years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_829 || Viral hepatitis, 65+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_830 || Viral hepatitis, 75+ years, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_831 || Viral hepatitis, per 100 000 population, by sex (age-standardized death rate) || 
|-
| HFAMDB_832 || Mid-year population, age 0 years, by sex || 
|-
| HFAMDB_833 || Mid-year population, age 10-14 years, by sex || 
|-
| HFAMDB_834 || Mid-year population, age 1-4 years, by sex || 
|-
| HFAMDB_835 || Mid-year population, age 15-19 years, by sex || 
|-
| HFAMDB_836 || Mid-year population, age 20-24 years, by sex || 
|-
| HFAMDB_837 || Mid-year population, age 25-29 years, by sex || 
|-
| HFAMDB_838 || Mid-year population, age 30-34 years, by sex || 
|-
| HFAMDB_839 || Mid-year population, age 35-39 years, by sex || 
|-
| HFAMDB_840 || Mid-year population, age 40-44 years, by sex || 
|-
| HFAMDB_841 || Mid-year population, age 45-49 years, by sex || 
|-
| HFAMDB_842 || Mid-year population, age 50-54 years, by sex || 
|-
| HFAMDB_843 || Mid-year population, age 55-59 years, by sex || 
|-
| HFAMDB_844 || Mid-year population, age 5-9 years, by sex || 
|-
| HFAMDB_845 || Mid-year population, age 60-64 years, by sex || 
|-
| HFAMDB_846 || Mid-year population, age 65-69 years, by sex || 
|-
| HFAMDB_847 || Mid-year population, age 70-74 years, by sex || 
|-
| HFAMDB_848 || Mid-year population, age 75-79 years, by sex || 
|-
| HFAMDB_849 || Mid-year population, age 80-84 years, by sex || 
|-
| HFAMDB_850 || Mid-year population, age 85+ years, by sex || 
|-
| HFAMDB_851 || Classification version used to code underlying cause of death (see Definitions) || 
|-
|  ||  || 
|-
| Measure related labels ||  || 
|-
| UNIT_TYPE || Unit || 
|-
| NUM_PERS || number of persons || 
|-
| NUM_DTH || number of deaths || 
|-
| DTH_100K || deaths per 100 000 || 
|-
| ICD_VERSION || Version used || 
|-
|  ||  || 
|-
| EXTERNID || ID in the originating data source || 
|-
|  ||  || 
|-
| DATA_SOURCE || Data source || 
|-
| HFA || European Health for All database || 
|-
| HFAMDB || European mortality database (MDB) || 
|-
|  ||  || 
|-
| DATA_TYPE_REPRESENTATION || Data type representation || 
|-
| COUNT || Count || 
|-
| RATE || Rate || 
|-
|  ||  || 
|-
| DATA_SET || Data set || 
|-
| HFA || European Health for All database (WHO) || 
|-
| CAH || Child and Adolescent Health and Development Strategy Indicators || 
|-
| HFAMDB || European mortality database (MDB) || 
|-
|  ||  || 
|-
| DATA_MASK || Mask for controlling the output format of values || 
|-
|  ||  || 
|-
| Fact-attribute labels ||  || 
|-
| Code || Alias || Label
|-
| COUNTRY || COUNTRY_REGION || Country
|-
| COUNTRY_GRP || COUNTRY_REGION || Supranational group of countries
|-
| SEX ||  || Sex
|-
| YEAR ||  || Year of measure
|-
| AGE_GRP_LIST || AGE_GRP || Age group
|-
| AGE_GRP_5 || AGE_GRP || Age group
|-
| AGE_GRP_4 || AGE_GRP || Age group
|-
| AGE_GRP_6 || AGE_GRP || Age group
|-
|  ||  || 
|-
| Fact-attribute coded list labels ||  || 
|-
| Attribute code || Coded value || Label
|-
| SEX || FEMALE || Female
|-
| SEX || MALE || Male
|-
| SEX || ALL || All
|-
| AGE_GRP_LIST || TOTAL || Total
|-
| AGE_GRP_5 || 0_14 || 0-14
|-
| AGE_GRP_5 || 15_29 || 15-29
|-
| AGE_GRP_5 || 30_44 || 30-44
|-
| AGE_GRP_5 || 45_59 || 45-59
|-
| AGE_GRP_5 || 60_74 || 60-74
|-
| AGE_GRP_5 || ALL || All
|-
| AGE_GRP_5 || GTE75 || 75+
|-
| AGE_GRP_4 || 0_64 || 0-64
|-
| AGE_GRP_4 || ALL || All
|-
| AGE_GRP_4 || GTE65 || 65+
|-
| AGE_GRP_6 || 0 || 0 year
|-
| AGE_GRP_6 || 01_04 || 1-4
|-
| AGE_GRP_6 || 05_09 || 5-9
|-
| AGE_GRP_6 || 10_14 || 10-14
|-
| AGE_GRP_6 || 15_19 || 15-19
|-
| AGE_GRP_6 || 20_24 || 20-24
|-
| AGE_GRP_6 || 25_29 || 25-29
|-
| AGE_GRP_6 || 30_34 || 30-34
|-
| AGE_GRP_6 || 35_39 || 35-39
|-
| AGE_GRP_6 || 40_44 || 40-44
|-
| AGE_GRP_6 || 45_49 || 45-49
|-
| AGE_GRP_6 || 50_54 || 50-54
|-
| AGE_GRP_6 || 55_59 || 55-59
|-
| AGE_GRP_6 || 60_64 || 60-64
|-
| AGE_GRP_6 || 65_69 || 65-69
|-
| AGE_GRP_6 || 70_74 || 70-74
|-
| AGE_GRP_6 || 75_79 || 75-79
|-
| AGE_GRP_6 || 80_84 || 80-84
|-
| AGE_GRP_6 || ALL || All
|-
| AGE_GRP_6 || GTE85 || 85+
|}